Related Experiment Video
Updated: May 18, 2026

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered
Xiaohong Jiang1, Yuan-Chuan Chen, Hao Gong
1School of Public Health, University of California, Berkeley, CA USA.
Abstract:
External guide sequences (EGSs) are RNA molecules that can bind to a target mRNA and direct ribonuclease P (RNase P), a tRNA processing enzyme, for specific cleavage of the target mRNA. Using an in vitro selection procedure, we have previously generated EGS variants that efficiently direct human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the mRNAs coding for human cytomegalovirus (HCMV) capsid scaffolding protein (CSP) and assemblin, which are essential for viral capsid formation. The EGS variant was about 40-fold more active in directing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Moreover, a reduction of about 98% and 75% in CSP/assemblin gene expression and a reduction of 7000- and 250-fold in viral growth were observed in HCMV-infected cells that expressed the variant and the tRNA-derived EGS, respectively. Our study shows that the EGS variant is more effective in blocking HCMV gene expression and growth than the tRNA-derived EGS. Moreover, these results demonstrate the utility of highly active EGS RNA variants in gene targeting applications including anti-HCMV therapy.
Insights
Engineered external guide sequences (EGSs) effectively target human cytomegalovirus (HCMV) mRNA, significantly reducing viral gene expression and growth. This demonstrates EGS RNA variants
Area of Science:
- Molecular Biology
- RNA Therapeutics
- Virology
Background:
- External guide sequences (EGSs) are RNA molecules that guide ribonuclease P (RNase P) to cleave specific mRNA targets.
- Previous work generated EGS variants with high in vitro activity for mRNA cleavage.
Purpose of the Study:
- To construct EGSs targeting the overlapping mRNA of human cytomegalovirus (HCMV) capsid scaffolding protein (CSP) and assemblin.
- To evaluate the efficacy of a novel EGS variant in inhibiting HCMV gene expression and viral replication.
Main Methods:
- In vitro selection to generate EGS variants.
- Construction of EGSs targeting HCMV CSP/assemblin mRNA.
- Assessing EGS activity in HCMV-infected cells for gene expression and viral growth reduction.
Main Results:
- The engineered EGS variant showed 40-fold higher activity than a tRNA-derived EGS in directing RNase P cleavage.
- HCMV-infected cells expressing the variant EGS exhibited 98% reduction in CSP/assemblin gene expression.
- Significant reductions in viral growth (7000-fold) were observed with the variant EGS compared to the tRNA-derived EGS (250-fold).
Conclusions:
- The engineered EGS variant is highly effective in blocking HCMV gene expression and viral propagation.
- These findings highlight the potential of active EGS RNA variants for anti-HCMV gene targeting therapies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Viruses with RNA Genomes
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

